Arimak Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 13-12-2024
- Paid Up Capital ₹ 0.15 M
as on 13-12-2024
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 M
as on 13-12-2024
- Revenue -5.26%
(FY 2023)
- Profit -8.30%
(FY 2023)
- Ebitda -4.20%
(FY 2023)
- Net Worth 24.72%
(FY 2023)
- Total Assets 17.31%
(FY 2023)
About Arimak Laboratories
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.15 M.
The company currently has active open charges totaling ₹2.00 M.
Rajesh Kothari, Ranjeet Kothari, and Archana Kothari serve as directors at the Company.
- CIN/LLPIN
U33300MH2019PTC318936
- Company No.
318936
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jan 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Aurangabad, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Arimak Laboratories?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Kothari  | Director | 02-Jan-2019 | Current |
| Ranjeet Kothari | Director | 19-May-2023 | Current |
| Archana Kothari | Director | 17-May-2019 | Current |
Financial Performance of Arimak Laboratories.
Arimak Laboratories Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 5.26% decrease. The company also saw a slight decrease in profitability, with a 8.3% decrease in profit. The company's net worth Soared by an impressive increase of 24.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arimak Laboratories?
Unlock access to Arimak Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Dkr Urban Insurance Brokers Private LimitedActive 2 months 29 daysRajesh Kothari is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 29 Aug 2023 | ₹2.00 M | Open |
How Many Employees Work at Arimak Laboratories?
Unlock and access historical data on people associated with Arimak Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arimak Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arimak Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
